Hepatitis C: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• BCL-2 0
• IL-1 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

  NCT06082336· MagIA Diagnostics· Updated 11 Sept 2026

  “Liquidation of MagIA Diagnostics”Registry text, quoted unchanged. Source

• Terminated

  Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

  NCT03981211· Kirby Institute· Updated 26 May 2026

  “The study was impacted by the COVID-19 pandemic. Once recruitment recommenced it remained slow. Removal of Sofosbuvir from the PBS November 2020 impacted recruitment into Cohort B. Study closed early on 15-Sep-26.”Registry text, quoted unchanged. Source

• Withdrawn

  Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)

  NCT05649202· Assistance Publique - Hôpitaux de Paris· Updated 6 May 2026

  “No patient eligible”Registry text, quoted unchanged. Source

• Terminated

  Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C

  NCT06564051· Mayo Clinic· Updated 6 Jan 2026

  “slow accrual”Registry text, quoted unchanged. Source

• Terminated

  HCV Test and Treat Utilizing Simplified HCV Patient Education

  NCT05582681· Weill Medical College of Cornell University· Updated 27 Feb 2025

  “The funding was halted.”Registry text, quoted unchanged. Source

• Suspended

  Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

  NCT02935478· St. Louis University· Updated 6 Feb 2025

  “IRB reviewing study conduct and adverse events”Registry text, quoted unchanged. Source

• Terminated

  Hepatitis C Lab Testing Comparison Study

  NCT06380166· HealthPartners Institute· Updated 6 Jan 2025

  “We had difficulty recruiting this population and enrolled only one patient.”Registry text, quoted unchanged. Source

• Terminated

  Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

  NCT05717400· M.D. Anderson Cancer Center· Updated 31 Dec 2024

  “PI Request”Registry text, quoted unchanged. Source

• Terminated

  Utilization of MAsS in Patients Undergoing LT for HCC

  NCT05184283· Columbia University· Updated 7 Dec 2023

  “Discontinued by Amra Medical due to funding.”Registry text, quoted unchanged. Source

• Withdrawn

  Hepatitis C Treatment Study in Myanmar

  NCT03158857· Myanmar Oxford Clinical Research Unit· Updated 17 Dec 2021

  “Long local IRB process to meet with the treatment deadline”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Elimination of Hepatitis C Virus Among Users of Substances

  NCT05503979· Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran· Source

• Twelve Weeks Sofosbuvir/Daclatasvir in HCV Infected Children Aged 6-18 Years

  NCT07905989· National Liver Institute, Egypt· Source

• The Kentucky Viral Hepatitis Treatment Study

  NCT03949764· Jennifer Havens· Source

• Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy

  NCT05140941· Catherine Anne Chappell· Source

• Persuasive Health Communication Intervention for HIV/HCV

  NCT05968573· University of South Florida· Source

• Blood Collection Biorepository for Liver Disease Research

  NCT03025074· State University of New York at Buffalo· Source

• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

  NCT05832229· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Source

• Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

  NCT05286879· Yale University· Source

• Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine

  NCT07569211· Ukrainian Institute on Public Health Policy· Source

• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

  NCT07040319· National Institute of Allergy and Infectious Diseases (NIAID)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.